Study of Cognitive Reserve Disorder Affecting Depression in Aged Related Hearing Loss Via Rest State EEG
1 other identifier
observational
44
1 country
1
Brief Summary
In this study, patients with aged-related hearing loss with depression and without depression were evaluated by audiometry (pure tone audiometry and speech audiometry), cognitive function assessment (MMSE scale for simple mental state test, MoCA Scale for Montreal Cognitive Assessment), and depressive symptoms assessment (GDS-15 and HAMD), resting state EEG. The ananlysis of resting state EEG included power spectral density, traceability analysis, functional connectivity, microstate, clustering coefficient, characteristic path length, characteristic path permeability, and compatibility coefficient. EEG signals were used to explore the activation of brain regions and poor connectivity of brain regions affected by cognitive reserve dissonance on the level of brain imaging. This paper innovatively explores the influence of cognitive reserve dissonance on depressive mood in senile deafness by means of audiological assessment, cognitive function assessment, depression symptom assessment, resting state electroencephalography (EEG) and other technical means. Auditory and cognitive cortical activation, functional connectivity of brain regions, small-world attributes and microstates were analyzed in senile deafness with or without depression at the brain imaging level.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 8, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 16, 2023
CompletedFirst Submitted
Initial submission to the registry
May 25, 2023
CompletedFirst Posted
Study publicly available on registry
June 7, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedJune 7, 2023
January 1, 2023
2 months
May 25, 2023
June 6, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
score of Montreal Cognitive Assessment scale
The Montreal Cognitive Assessment Scale(MoCA) is an assessment tool used to rapidly screen for cognitive abnormalities. The test included 11 tests in eight cognitive areas, including attention and concentration, executive function, memory, language, visual structure skills, abstract thinking, calculation, and orientation. Total score of 30 points, and the score of high school/technical secondary school or below needs to be added 1 point. Level: Normal 26-30 , mild cognitive impairment(MCI) 18-25, moderate cognitive impairment 10-17, severe cognitive impairment 0-9.
1 day of enrollment
score of Mini-mental State Examination
Mini-mental State Examination (MMSE) is a scale for screening cognitive impairment and is widely used in dementia screening. The scale is divided into seven aspects, including time orientation, place orientation, immediate memory, attention and gauging, delayed memory, language and visual space. There are 30 items in the scale, with a total score of 30. The scale is 27 to 30 points normal, 21 to 26 points mild cognitive impairment, 10 to 20 points moderate cognitive impairment, and 0 to 9 points severe cognitive impairment.
1 day of enrollment
Secondary Outcomes (5)
pure tone average
1 day of enrollment
speech acceptance threshold
1 day of enrollment
Maximum speech recognition score
1 day of enrollment
score of 15-item Geriatric Depression Scale
1 day of enrollment
score of HAMD scale
1 day of enrollment
Study Arms (2)
age-related hearing loss with depression
According to Hamilton depression scale, age-related hearing loss patients were divided into two groups, namely age-related hearing loss with depression and age-related hearing loss without depression.
age-related hearing loss without depression
According to Hamilton depression scale, age-related hearing loss patients were divided into two groups, namely age-related hearing loss with depression and age-related hearing loss without depression.
Interventions
age-related hearing loss with depression
age-related hearing loss without depression
Eligibility Criteria
In this study, PASS 15.0 was used to calculate the sample size, and the number of cases was arranged in a 1:1 ratio. The test efficacy was 1-β = 0.9, the test level was α = 0.05, σ=3.0. 17 cases were required in each group. Considering the 20% shedding rate, 22 cases were required in each group. Consequently, 44 cases of age-related hearing loss were included in this study.
You may qualify if:
- age ≥55 years, \< 90 years;
- For patients diagnosed with senile deafness, refering to Expert Consensus on Diagnosis and Intervention of Senile Hearing Loss, 2019 edition.
- mild, moderate, moderate and severe sensorineural hearing loss;
- Chinese who can cooperate with all Chinese version evaluation;
- right-handed;
- there was no middle ear disease or inner ear disease;
- there was no bilateral symmetry or sensorineural deafness;
- there was no severe neurological disease, serious systemic disease, family genetic history, or severe mental disease;
- there was no experience of hearing aids fitting.
You may not qualify if:
- pure tone audiometry suggests that the average pure tone hearing threshold (500Hz, 1kHz, 2kHz, 4kHz) is \> 91dB HL;
- sensorineural hearing loss caused by noise or drugs.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Guangzhou, Guangdong, 510000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 25, 2023
First Posted
June 7, 2023
Study Start
February 8, 2023
Primary Completion
April 16, 2023
Study Completion
December 31, 2023
Last Updated
June 7, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will not share